Graduate & Postdoctoral Studies

Spotlight on Faculty

Mark J. Fenske

Mark J. Fenske

My lab combines measures of human behaviour with brain imaging techniques, such as functional Magnetic Resonance Imaging (fMRI), to examine the cognitive and neural mechanisms of visual recognition and affective response, and how...

Email: mfenske@uoguelph.ca

Portrait of professor Leith Deacon

Leith Deacon

The central research goal of my research is to examine the concept of resiliency and sustainability within the context of resource-based communities to address the often problematic relationship(s) between resource reliance, community well-being, and adaptive capacity.

Email: Leith.Deacon@uoguelph.ca

Portrait of Stephen Seah

Stephen Seah

We are interested in structure-function relationships of enzymes and enzyme evolution. We are studying steroid degrading enzymes from the pathogen Mycobacterium tuberculosis and other related bacteria. We are also interested in enzymes that can be used to detoxify environmental pollutants.

Email: sseah@uoguelph.ca

Portrait of Dr. Kate Parizeau

Kate Parizeau

Dr. Kate Parizeau is interested in research questions concerning the social context of waste and its management. Her research uses waste management practices as a lens through which to interrogate complex systems of social organization and human exchanges with the natural world.

Email: kate.parizeau@uoguelph.ca

Headshot of Karl Cottenie

Karl Cottenie

I employ a quantitative approach to integrate observational, experimental and synthetic data sets, gathered by myself and others, to study this interaction of dispersal and environmental processes...

Email: cottenie@uoguelph.ca

Portrait of graduate faculty Courtney R. Schott (Pathobiology PhD, DVSc, MSc)

Courtney R. Schott

About my research:

Osteosarcoma is an aggressive bone cancer in dogs and people. My lab investigates the mechanisms that permit osteosarcoma cells to spread to new sites (metastasis) and survive exposure to chemotherapy (chemoresistance). Additionally, we are working on identifying biomarkers that can help predict outcomes and/or guide therapeutic decisions for patients with osteosarcoma.